Professor Tuccinardi

Tiziano Tuccinardi was born in Pisa in November 1977.

He graduated in C.T.F (Pharmaceutical chemistry and technologies, a five-year degree course) at the Faculty of Pharmacy of the University of Pisa in 2002 (Marks: 110/110 cum laude) and he obtained the PhD degree in Medicinal Chemistry from the same University in 2006.

From December 2007 to March 2015 he was appointed Assistant Professor at the Faculty of Pharmacy of the University of Pisa.

From November 2009 to July 2014 he was appointed Adjunct Assistant Professor at the Sbarro Institute for Cancer Research and Molecular Medicine, Center for Biotechnology, Temple University, Philadelphia, PA, USA.

From April 2015 he is appointed Assistant Professor at the Faculty of Pharmacy of the University of Pisa.

Since May 2022 he is Full Professor of Medicinal Chemistry at the Department of Pharmacy of the University of Pisa.

Since July 2016 he is Adjunct Associate Professor at the Department of Biology, Temple University’s College of Science and Technology, Philadelphia, PA, USA.

From November 2023 he is the Director of the PhD program “Science of Drug and Bioactive Substances”, Department of Pharmacy, University of Pisa.

From November 2018 he is the Director of the “Pharmaceutical Chemistry and Technology” MD (long cycle) programme, University of Pisa (click here).

He has published more than 200 papers with an H-index of 43 and more than 6000 citations.

In 2010, he was awarded with the ‘Farmindustria Prize for Pharmaceutical Research’, which is a national award dedicated to scientists younger than 40 years old.

From 2020 he is a member of the 2% top scientists for the Medicinal & Biomolecular Chemistry field; as reported by: 1) Ioannidis JPA, Boyack KW, Baas J. “Updated science-wide author databases of standardized citation indicators.” PLoS Biol. 2020 18(10):e3000918. doi: 10.1371/journal.pbio.3000918. 2) Ioannidis JPA “September 2022 data-update for “Updated science-wide author databases of standardized citation indicators.”” 2022, Mendeley Data, V5, doi: 10.17632/btchxktzyw.5. 3) Ioannidis JPA “October 2023 data-update for “Updated science-wide author databases of standardized citation indicators””, 2023, Elsevier Data Repository, V6, doi: 10.17632/btchxktzyw.6

In 2021, he was awarded the first edition of the ESMEC Alumni Award (First edition), a european award given to an outstanding European researcher in the field of Medicinal Chemistry who has participated in one of the forty editions of the European School of Medicinal Chemistry (ESMEC) either as an oral or poster presenter.

Since 2009, he has been a member of the Academic Board of the PhD program “Science of Drug and Bioactive Substances” (University of Pisa) and since 2023 he is also a member of the Academic Board of the PhD program “Genomic and experimental medicine (GEM)” (Scuola Superiore Meridionale, SSM).

He is Director of the “Computer-Aided Drug Design” International Summer School.

He is co-inventor of eight patents and he is a Scientific Advisory Board Member of the Bio Future Medicine (BFM) startup.

He is Editor in Chief of Mini-Reviews in Medicinal Chemistry (Bentham) and is a member of the Editorial Advisory Board of the following journals: Journal of Enzyme Inhibition & Medicinal Chemistry (Taylor & Francis), Bioorganic Chemistry (Elsevier) and Plos One (PLOS).

RESEARCH INTERESTS
His research interests include drug and lead discovery, with a focus on computer-assisted approaches and medicinal chemistry, including synthesis of small molecules, virtual and biomolecular screening.